Sunshine Biopharma
SBFM
4 hedge funds and large institutions have $415K invested in Sunshine Biopharma in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
67% less capital invested
Capital invested by funds: $1.25M → $415K (-$830K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$8.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$546K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$8.95K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $312K | -$546K | -61 | -55% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $89K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $6.28K | – | – | – |
|
|
HF
4
HRT Financial
New York
| $5K | +$8.95K | +1 | New |
|
5
National Bank of Canada
Montreal,
Quebec, Canada
| $1.87K | – | – | – |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $1.05K | -$8.95K | -1 | Closed |
|
|
NECFA
7
New England Capital Financial Advisors
Meriden,
Connecticut
| $160 | – | – | – |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $25 | – | – | – |
|
9
Morgan Stanley
New York
| $8 | – | – | – |
|
SBFM Hedge Fund Activity: Q3 2023 in Review
4 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma (SBFM) for Q3 2023, worth a combined $415K — down 67% from $1.25M a quarter earlier.
Fund positioning in SBFM was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $8.95K. The largest seller was Armistice Capital, cutting an estimated $546K.
- 4 institutional investors held Sunshine Biopharma (SBFM) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $415K of Sunshine Biopharma stock for Q3 2023, down 67% quarter-over-quarter.
- 1 fund opened new Sunshine Biopharma positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest Sunshine Biopharma buyer in Q3 2023 was HRT Financial, an estimated $8.95K added.
- The largest Sunshine Biopharma seller in Q3 2023 was Armistice Capital, an estimated $546K sold.
Based on aggregated 13F filings for Q3 2023.